Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
04/1999
04/29/1999WO1998057931A3 Quinoline-indole antimicrobial agents, uses and compositions related thereto
04/29/1999WO1998044134A3 Bacterial plasmids
04/29/1999DE19746868A1 Use of tumour necrosis factor antagonists
04/29/1999CA2308773A1 Estra-1,3,5(10)-triene-7alpha-thioethers
04/29/1999CA2307597A1 Pharmaceutically active compounds and methods of use
04/29/1999CA2307331A1 Passive immunization against clostridium difficile disease
04/29/1999CA2306995A1 Compositions and methods for systemic delivery of oral vaccines and therapeutic agents
04/29/1999CA2306983A1 Methods for treating hypercoagulable states or acquired protein c deficiency
04/29/1999CA2306965A1 Antibacterial carbapenems, compositions and methods of treatment
04/29/1999CA2306870A1 Bicyclic kinase inhibitors
04/29/1999CA2306698A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
04/29/1999CA2306632A1 Carbapenem antibacterial compounds, compositions and methods of treatment
04/29/1999CA2306565A1 Carbapenem antibacterial compounds, compositions and methods of treatment
04/29/1999CA2306445A1 Documentation means for repertoires of nkr immunoreceptors and/or activatory or non-inhibitory immunoreceptor counterparts of nkr immunoreceptors
04/29/1999CA2306204A1 J-chain and analogues as epithelial cell targeting conjugates
04/28/1999EP0911633A1 A method of identifying agonists and antagonists for tumor necrosis related receptors TR1, TR3 and TR5
04/28/1999EP0911410A2 Era polynucleotides and polypeptides from Streptococcus pneumoniae belonging to the GTPase family
04/28/1999EP0911409A2 Deformylase
04/28/1999EP0911407A1 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratC
04/28/1999EP0911406A2 Histidine kinase from Staphylococcus aureus
04/28/1999EP0911405A2 Gapdh
04/28/1999EP0911403A2 MurB gene from Streptococcus pneumoniae
04/28/1999EP0911402A2 PyrR homolog from Staphylococcus aureus
04/28/1999EP0911399A2 A kringle-related clone, HTHBZ47
04/28/1999EP0911388A2 Method for stimulation of T-cells with desired antigenspecificity
04/28/1999EP0911327A1 Novel pyridonecarboxylic acid derivatives or their salts and antibacterial agent comprising the same as the active ingredient
04/28/1999EP0911033A2 Methods and compositions for the treatment of diseases with interferon while reducing side effects
04/28/1999EP0911030A2 Antimicrobial composition comprising a vinyyl pyrrolidinon derivative and a carbapenem antibiotic or a beta-lactamase inhibitor
04/28/1999EP0910659A2 Antibodies against a complex of cd4 and a chemokine receptor domain, and their use against hiv infections
04/28/1999EP0910657A1 Canine herpesvirus based recombinant live vaccine, in particular against canine distemper, rabies or the parainfluenza 2 virus
04/28/1999EP0910656A1 Virus-like particles useful as a vector for delivering nucleic acid
04/28/1999EP0910645A1 A KINASE CAPABLE OF SITE-SPECIFIC PHOSPHORYLATION OF I-kappa-B-alpha
04/28/1999EP0910633A2 Polyketides and their synthesis
04/28/1999EP0910572A1 Inhibitors of picornavirus 3c proteases and methods for their use and preparation
04/28/1999EP0910460A1 Iodinated matrices for disinfecting biological fluids
04/28/1999EP0910428A1 Photopheresis treatment of chronic hcv infections
04/28/1999EP0910406A1 Recombinant canine herpesviruses
04/28/1999EP0910405A2 Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection
04/28/1999EP0910403A1 Stationary phase, stress response sigma factor from mycobacterium tuberculosis, and regulation thereof
04/28/1999EP0910377A1 Anti-vaginitis composition for topical use comprising one or more anti-vaginitis medicaments and one or more local anaesthetics
04/28/1999EP0910376A2 Use of clotrimazole and related compounds in the treatment of diarrhea
04/28/1999EP0910363A1 Veterinary use of a pleuromutilin derivative
04/28/1999EP0910354A1 Antioxidant compounds
04/28/1999EP0784629B1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases
04/28/1999EP0658119B1 New hiv-1 isolates of a subtype and its differential diagnosis, vaccine against hiv-1 infection of this subtype and process for preparing and using the hiv-1 isolate
04/28/1999EP0592480B1 Use of papillomavirus L2 protein for therapeutic treatment of papillomavirus tumours or lesions
04/28/1999EP0295248B2 Liposome preparation and antibiotic
04/28/1999CN1215431A Genomic nucleic acids, cDNA and mDNA which code for polypeptides with IL-16 activity, processes for the production thereof and their use
04/28/1999CN1215407A Human antibodies that bind huma TNF 'alpha'
04/28/1999CN1215404A Non-dendritic backbone piptide carrier
04/28/1999CN1215331A Injection formulations of avermectins and milbemycins based on castor oil
04/28/1999CN1215310A Method of killing or inhibiting microbial cells
04/28/1999CN1215058A Novel trichain formed eliyonucleotide structure and application to anti-virus of hepatitis B
04/28/1999CN1215056A Process for preparation of N-tertiary butyl amide
04/28/1999CN1214938A Frozen dried heptitis A toxicity-reduced bio-vaccine and protective agent thereof
04/28/1999CN1214910A Pharmaceutical application of crust holoside and derivant thereof
04/28/1999CN1043142C Quinolone and naphthyridone-carboxylic acid derivatives and preparation process
04/28/1999CA2248274A1 Novel dbpa
04/28/1999CA2248270A1 Novel dbpb
04/27/1999US5897867 Efficacious vaccines against Bordetella pertussis comprising a combination of individually purified pertussis antigens
04/27/1999US5897860 Hemostatic composition; treating ulcers, suturing blood vessels, treating hemophilia, inhibiting growth of microrganisms
04/27/1999US5897475 Vaccines comprising enhanced antigenic helicobacter spp.
04/27/1999CA2248119A1 Novel apt
04/27/1999CA2248116A1 Novel muty
04/27/1999CA2122246C Phospholipid antimicrobial compositions
04/27/1999CA2056823C Derivatives of 10,11,12,13-tetrahydrodesmycosin processes for preparation, and use thereof in pharmaceuticals
04/24/1999CA2248170A1 A clone hwhhj20
04/23/1999CA2239255A1 Cdna clone hneaa81 that encodes a human 7-transmembrane receptor
04/22/1999WO1999019732A1 Methods and compositions for detecting hepatitis e virus
04/22/1999WO1999019496A1 Inhibition of human immunodeficiency virus (hiv-1) replication
04/22/1999WO1999019481A2 Mammalian genes involved in viral infection and tumor suppression
04/22/1999WO1999019466A2 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
04/22/1999WO1999019349A1 Immuno-reactive peptide ctl epitopes of human cytomegalovirus
04/22/1999WO1999019304A2 Alpha-alkylthio substituted pyrimidine ethers and thioethers as viral reverse transcriptase inhibitors
04/22/1999WO1999018996A1 Enterococcus antigens and vaccines
04/22/1999WO1999018995A1 Immunogenic peptides from the hpv e7 protein
04/22/1999WO1999018962A1 Pharmaceutically active compound and methods of use
04/22/1999WO1999018954A1 Antibacterial carbapenems, compositions and methods of treatment
04/22/1999WO1999018950A1 Mixed cyanoacrylate ester compositions
04/22/1999WO1999006577A3 Agent for expressing and detecting a fusion polypeptide with an hpol-epitope and a polypeptide
04/22/1999WO1999001136A9 Novel substituted imidazole compounds
04/22/1999WO1998036779A3 System for the in vivo delivery and expression of heterologous genes in the bone marrow
04/22/1999WO1998021221A3 1-thiogalactose derivatives
04/22/1999DE19745583A1 New actagardine derivatives with extra N-terminal amino acid
04/22/1999CA2696653A1 Mammalian genes involved in viral infection and tumor suppression
04/22/1999CA2308118A1 Immuno-reactive peptide ctl epitopes of human cytomegalovirus
04/22/1999CA2306476A1 Enterococcus antigens and vaccines
04/22/1999CA2306451A1 Methods and compositions for detecting hepatitis e virus
04/22/1999CA2306444A1 Inhibition of human immunodeficiency virus (hiv-1) replication
04/22/1999CA2306443A1 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
04/22/1999CA2306399A1 Antibacterial carbapenems, compositions and methods of treatment
04/22/1999CA2306276A1 Pharmaceutically active compound and methods of use
04/22/1999CA2304457A1 Mixed cyanoacrylate ester compositions
04/22/1999CA2301800A1 Thioalkyl alpha substituted pyrimidine compounds
04/21/1999EP0909820A2 Histidine kinase from Staphylococcus pneumoniae
04/21/1999EP0909759A2 Individual stereoisomers of 7-(3-aminoalkyl)-1-pyrrolidinyl)-quinolones as antibacterial agents
04/21/1999EP0909557A1 Use of honey as an agent for decreasing micro-organisms adhesion
04/21/1999EP0909327A2 Erythromycins and process for their preparation
04/21/1999EP0909272A1 Helicobacter pylori adhesin binding group antigen
04/21/1999EP0909184A2 Targeted drug delivery using sulfonamide derivatives
1 ... 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 ... 1798